Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2023 Earnings Call Transcript August 8, 2023
Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.42, expectations were $0.76.
Operator: Thank you for standing by. My name is Brian, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ligand Second Quarter 2023 Earnings Webcast. [Operator Instructions] Thank you. Simon Latimer, Head of Investor Relations, you may...
